317 related articles for article (PubMed ID: 9036878)
1. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression.
Caligo MA; Cipollini G; Berti A; Viacava P; Collecchi P; Bevilacqua G
Int J Cancer; 1997 Feb; 74(1):102-11. PubMed ID: 9036878
[TBL] [Abstract][Full Text] [Related]
2. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
3. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the expression levels of nm23-H1 mRNA in primary breast cancer, benign breast disease, axillary lymph nodes and normal breast tissue.
Goodall RJ; Dawkins HJ; Robbins PD; Hähnel E; Sarna M; Hähnel R; Papadimitriou JM; Harvey JM; Sterrett GF
Pathology; 1994 Oct; 26(4):423-8. PubMed ID: 7892043
[TBL] [Abstract][Full Text] [Related]
5. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.
Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS
Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901
[TBL] [Abstract][Full Text] [Related]
6. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
7. Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings.
Dueñas-González A; Abad-Hernández MM; García-Mata J; Paz-Bouza JI; Cruz-Hernández JJ; González-Sarmiento R
Cancer Lett; 1996 Mar; 101(2):137-42. PubMed ID: 8620461
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer.
Tokunaga Y; Urano T; Furukawa K; Kondo H; Kanematsu T; Shiku H
Int J Cancer; 1993 Aug; 55(1):66-71. PubMed ID: 8102131
[TBL] [Abstract][Full Text] [Related]
9. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.
Tannapfel A; Köckerling F; Katalinic A; Wittekind C
Dis Colon Rectum; 1995 Jun; 38(6):651-4. PubMed ID: 7774480
[TBL] [Abstract][Full Text] [Related]
10. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.
Tannapfel A; Katalinic A; Köckerling F; Wittekind C
Am J Gastroenterol; 1997 Jul; 92(7):1182-6. PubMed ID: 9219795
[TBL] [Abstract][Full Text] [Related]
11. Expression of nm23-H1 gene product in thyroid, ovary, and breast cancers.
Okubo T; Inokuma S; Takeda S; Itoyama S; Kinoshita K; Sugawara I
Cell Biophys; 1995 Jun; 26(3):205-13. PubMed ID: 8521452
[TBL] [Abstract][Full Text] [Related]
12. nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy.
Sauer T; Furu I; Beraki K; Jebsen PW; Ormerod E; Naess O
Cancer; 1998 Apr; 84(2):109-14. PubMed ID: 9570214
[TBL] [Abstract][Full Text] [Related]
13. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].
Liu H; Mao H; Fu X
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):224-7. PubMed ID: 11783092
[TBL] [Abstract][Full Text] [Related]
14. [mRNA expression of metastasis-suppressor gene nm23 in carcinoma of buccal mucosa I. Northern blotting study].
Lu Y; Li C; Zhou Z
Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):143-6. PubMed ID: 11480034
[TBL] [Abstract][Full Text] [Related]
15. Activation of antimetastatic Nm23-H1 gene expression by estrogen and its alpha-receptor.
Lin KH; Wang WJ; Wu YH; Cheng SY
Endocrinology; 2002 Feb; 143(2):467-75. PubMed ID: 11796500
[TBL] [Abstract][Full Text] [Related]
16. [Study on expression of nm23-H1 gene in laryngeal cancer tissues].
Wang Q; Guo M; Sun L
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):198-200. PubMed ID: 9642340
[TBL] [Abstract][Full Text] [Related]
17. [Low expression of nm23-H1 mRNA and its protein in breast cancer].
Guo W; Wang Y; Zhuang X; Bai Y; Zhang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):91-3. PubMed ID: 10751528
[TBL] [Abstract][Full Text] [Related]
18. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.
Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G
Oncology; 1998; 55(4):357-62. PubMed ID: 9663428
[TBL] [Abstract][Full Text] [Related]
19. Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas.
Charpin C; Bouvier C; Garcia S; Martini F; Andrac L; Lavaut MN; Allasia C
Int J Cancer; 1997 Aug; 74(4):416-20. PubMed ID: 9291431
[TBL] [Abstract][Full Text] [Related]
20. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
Iizuka N; Oka M; Noma T; Nakazawa A; Hirose K; Suzuki T
Cancer Res; 1995 Feb; 55(3):652-7. PubMed ID: 7530600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
